Experimental studies of the potentiation of proguanil and pyrimethamine by dapsone using Plasmodium berghei in white mice.
An accurate system with stringent criteria has been established to test antimalarial drugs and drug combinations against Plasmodium berghei in mice. Minimum effective doses for a number of antimalarial drugs have been determined when used in this system. Considerable potentiation of the activity of pyrimethamine and to a somewhat less extent of proguanil by dapsone has been demonstrated. The need to extend studies of these combinations to the parasites of human malaria is discussed in terms of establishing a safe chemoprophylactic regime in the presence of drug-resistant strains of parasites.
D000818:Animals; D002738:Chloroquine / Q000494:pharmacology; D003622:Dapsone / Q000494:pharmacology*; D004357:Drug Synergism; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects*; D002727:Proguanil / Q000494:pharmacology*; D011739:Pyrimethamine / Q000494:pharmacology*
D002738:Chloroquine; D003622:Dapsone; D002727:Proguanil; D011739:Pyrimethamine